184 related articles for article (PubMed ID: 3021732)
1. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
van Zonneveld AJ; Veerman H; Pannekoek H
J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732
[TBL] [Abstract][Full Text] [Related]
2. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
Bakker AH; Nieuwenbroek NM; Verheijen JH
Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
[TBL] [Abstract][Full Text] [Related]
3. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU
J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612
[TBL] [Abstract][Full Text] [Related]
4. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
de Munk GA; Caspers MP; Chang GT; Pouwels PH; Enger-Valk BE; Verheijen JH
Biochemistry; 1989 Sep; 28(18):7318-25. PubMed ID: 2510823
[TBL] [Abstract][Full Text] [Related]
5. Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator.
Bakker AH; van der Greef W; Rehberg EF; Marotti KR; Verheijen JH
J Biol Chem; 1993 Sep; 268(25):18496-501. PubMed ID: 8395505
[TBL] [Abstract][Full Text] [Related]
6. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
Bakker AH; Rehberg EF; Marotti KR; Verheijen JH
Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
Stewart RJ; Fredenburgh JC; Weitz JI
J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
[TBL] [Abstract][Full Text] [Related]
8. The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain.
VĂ¡li Z; Patthy L
J Biol Chem; 1984 Nov; 259(22):13690-4. PubMed ID: 6094526
[TBL] [Abstract][Full Text] [Related]
9. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
10. Interaction of plasminogen and fibrin in plasminogen activation.
Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
[TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
Novokhatny V; Medved L; Lijnen HR; Ingham K
J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
[TBL] [Abstract][Full Text] [Related]
12. Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain.
Gething MJ; Adler B; Boose JA; Gerard RD; Madison EL; McGookey D; Meidell RS; Roman LM; Sambrook J
EMBO J; 1988 Sep; 7(9):2731-40. PubMed ID: 2846282
[TBL] [Abstract][Full Text] [Related]
13. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis.
Weening-Verhoeff EJ; Quax PH; van Leeuwen RT; Rehberg EF; Marotti KR; Verheijen JH
Protein Eng; 1990 Dec; 4(2):191-8. PubMed ID: 1963688
[TBL] [Abstract][Full Text] [Related]
14. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.
Verheijen JH; Caspers MP; Chang GT; de Munk GA; Pouwels PH; Enger-Valk BE
EMBO J; 1986 Dec; 5(13):3525-30. PubMed ID: 3030730
[TBL] [Abstract][Full Text] [Related]
15. Replacement of finger and growth factor domains of tissue plasminogen activator with plasminogen kringle 1. Biochemical and pharmacological characterization of a novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.
Langer-Safer PR; Ahern TJ; Angus LB; Barone KM; Brenner MJ; Horgan PG; Morris GE; Stoudemire JB; Timony GA; Larsen GR
J Biol Chem; 1991 Feb; 266(6):3715-23. PubMed ID: 1847387
[TBL] [Abstract][Full Text] [Related]
16. The role of the lysyl binding site of tissue-type plasminogen activator in the interaction with a forming fibrin clot.
Bakker AH; Weening-Verhoeff EJ; Verheijen JH
J Biol Chem; 1995 May; 270(21):12355-60. PubMed ID: 7759476
[TBL] [Abstract][Full Text] [Related]
17. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
de Vries C; Veerman H; Koornneef E; Pannekoek H
J Biol Chem; 1990 Aug; 265(23):13547-52. PubMed ID: 2143185
[TBL] [Abstract][Full Text] [Related]
18. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
Nesheim M; Fredenburgh JC; Larsen GR
J Biol Chem; 1990 Dec; 265(35):21541-8. PubMed ID: 2123871
[TBL] [Abstract][Full Text] [Related]
19. Identification of the domains of tissue-type plasminogen activator involved in the augmented binding to fibrin after limited digestion with plasmin.
de Vries C; Veerman H; Pannekoek H
J Biol Chem; 1989 Jul; 264(21):12604-10. PubMed ID: 2526127
[TBL] [Abstract][Full Text] [Related]
20. Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Kaneko M; Sakata Y; Matsuda M; Mimuro J
J Biochem; 1992 Feb; 111(2):244-8. PubMed ID: 1314812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]